FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

385229008: Conventional release solution for infusion (dose form)


Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3654667019 Solution for infusion en Synonym Active Entire term case insensitive SNOMED CT core module
3655105015 Conventional release solution for infusion en Synonym Active Entire term case insensitive SNOMED CT core module
3655106019 Conventional release solution for infusion (dose form) en Fully specified name Active Entire term case insensitive SNOMED CT core module


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Conventional release solution for infusion Is a Type of drug preparation false Inferred relationship Existential restriction modifier
Conventional release solution for infusion Is a Drug solution false Inferred relationship Existential restriction modifier
Conventional release solution for infusion Has active ingredient Pharmaceutical fluid or solution agent false Inferred relationship Existential restriction modifier
Conventional release solution for infusion Is a Parenteral dose form false Inferred relationship Existential restriction modifier
Conventional release solution for infusion Has state of matter Liquid false Inferred relationship Existential restriction modifier
Conventional release solution for infusion Has dose form intended site Parenteral true Inferred relationship Existential restriction modifier
Conventional release solution for infusion Has dose form administration method Infuse true Inferred relationship Existential restriction modifier
Conventional release solution for infusion Has dose form transformation No transformation true Inferred relationship Existential restriction modifier
Conventional release solution for infusion Has dose form release characteristic Conventional release true Inferred relationship Existential restriction modifier
Conventional release solution for infusion Has basic dose form Solution true Inferred relationship Existential restriction modifier
Conventional release solution for infusion Is a Conventional release solution for infusion and/or injection true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Levetiracetam 500mg/5ml solution for infusion ampoules 10 ampoule Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Desitrend 500mg/5ml concentrate for solution for infusion ampoules (Desitin Pharma Ltd) 10 ampoule Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Isosorbide dinitrate 25mg/50ml solution for infusion vials (Special Order) 1 vial Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Isosorbide dinitrate 25mg/50ml solution for infusion vials (Special Order) 10 vial Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Isosorbide dinitrate 50mg/50ml solution for infusion vials (Special Order) 1 vial Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Isosorbide dinitrate 50mg/50ml solution for infusion vials (Special Order) 10 vial Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Morphine sulfate 3mg/50ml solution for infusion vials (Special Order) 1 vial Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Morphine sulfate 3mg/50ml solution for infusion vials (Special Order) 10 vial Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Normal immunoglobulin human 30g/300ml solution for infusion vials Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Recombinant human hyaluronidase solution for infusion 1.25ml vials Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Recombinant human hyaluronidase solution for infusion 15ml vials Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Recombinant human hyaluronidase solution for infusion 2.5ml vials Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Recombinant human hyaluronidase solution for infusion 5ml vials Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Recombinant human hyaluronidase solution for infusion 10ml vials Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Zoledronic acid 4mg/5ml concentrate for solution for infusion vials (Hospira UK Ltd) Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Fluorouracil 5g/100ml solution for infusion vials (A A H Pharmaceuticals Ltd) Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Zoledronic acid 4mg/5ml solution for infusion vials (A A H Pharmaceuticals Ltd) Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Normal immunoglobulin human 2.5g/25ml solution for infusion vials (Takeda UK Ltd) Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Recombinant human hyaluronidase solution for infusion 1.25ml vials (Takeda UK Ltd) Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Normal immunoglobulin human 5g/50ml solution for infusion vials (Takeda UK Ltd) Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Recombinant human hyaluronidase solution for infusion 2.5ml vials (Takeda UK Ltd) Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Normal immunoglobulin human 10g/100ml solution for infusion vials (Takeda UK Ltd) Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Recombinant human hyaluronidase solution for infusion 5ml vials (Takeda UK Ltd) Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Normal immunoglobulin human 20g/200ml solution for infusion vials (Takeda UK Ltd) Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Recombinant human hyaluronidase solution for infusion 10ml vials (Takeda UK Ltd) Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Normal immunoglobulin human 30g/300ml solution for infusion vials (Takeda UK Ltd) Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Recombinant human hyaluronidase solution for infusion 15ml vials (Takeda UK Ltd) Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Recombinant human hyaluronidase solution for infusion 15ml vials 1 vial Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Normal immunoglobulin human 30g/300ml solution for infusion vials 1 vial Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Recombinant human hyaluronidase solution for infusion 10ml vials 1 vial Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Recombinant human hyaluronidase solution for infusion 5ml vials 1 vial Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Recombinant human hyaluronidase solution for infusion 2.5ml vials 1 vial Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Recombinant human hyaluronidase solution for infusion 1.25ml vials 1 vial Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Zoledronic acid 4mg/5ml concentrate for solution for infusion vials (Hospira UK Ltd) 1 vial Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Fluorouracil 5g/100ml solution for infusion vials (A A H Pharmaceuticals Ltd) 1 vial Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Zoledronic acid 4mg/5ml solution for infusion vials (A A H Pharmaceuticals Ltd) 1 vial Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Normal immunoglobulin human 2.5g/25ml solution for infusion vials (Takeda UK Ltd) 1 vial Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Recombinant human hyaluronidase solution for infusion 1.25ml vials (Takeda UK Ltd) 1 vial Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Normal immunoglobulin human 5g/50ml solution for infusion vials (Takeda UK Ltd) 1 vial Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Recombinant human hyaluronidase solution for infusion 2.5ml vials (Takeda UK Ltd) 1 vial Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Normal immunoglobulin human 10g/100ml solution for infusion vials (Takeda UK Ltd) 1 vial Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Recombinant human hyaluronidase solution for infusion 5ml vials (Takeda UK Ltd) 1 vial Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Normal immunoglobulin human 20g/200ml solution for infusion vials (Takeda UK Ltd) 1 vial Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Recombinant human hyaluronidase solution for infusion 10ml vials (Takeda UK Ltd) 1 vial Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Normal immunoglobulin human 30g/300ml solution for infusion vials (Takeda UK Ltd) 1 vial Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Recombinant human hyaluronidase solution for infusion 15ml vials (Takeda UK Ltd) 1 vial Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Monosodium glutamate monohydrate 4.276g/100ml / Monosodium aspartate monohydrate 3.924g/100ml solution for infusion bottles Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Aspartate Glutamate 0.456molar solution for infusion 100ml bottles (Special Order) Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Docetaxel 80mg/2.88ml concentrate for solution for infusion vials and diluent (A A H Pharmaceuticals Ltd) Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Monosodium glutamate monohydrate 4.276g/100ml / Monosodium aspartate monohydrate 3.924g/100ml solution for infusion bottles 1 bottle Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Aspartate Glutamate 0.456molar solution for infusion 100ml bottles (Special Order) 1 bottle Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Docetaxel 80mg/2.88ml concentrate for solution for infusion vials and diluent (A A H Pharmaceuticals Ltd) 1 vial Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Gemcitabine 1g/26.3ml concentrate for solution for infusion vials (A A H Pharmaceuticals Ltd) Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Gemcitabine 200mg/5.3ml concentrate for solution for infusion vials (A A H Pharmaceuticals Ltd) Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Gemcitabine 1g/26.3ml concentrate for solution for infusion vials (A A H Pharmaceuticals Ltd) 1 vial Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Gemcitabine 200mg/5.3ml concentrate for solution for infusion vials (A A H Pharmaceuticals Ltd) 1 vial Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Topotecan 1mg/1ml concentrate for solution for infusion vials (A A H Pharmaceuticals Ltd) Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Topotecan 4mg/4ml concentrate for solution for infusion vials (A A H Pharmaceuticals Ltd) Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Topotecan 1mg/1ml concentrate for solution for infusion vials (A A H Pharmaceuticals Ltd) 5 vial Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Topotecan 4mg/4ml concentrate for solution for infusion vials (A A H Pharmaceuticals Ltd) 5 vial Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Nivolumab 100mg/10ml solution for infusion vials Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Nivolumab 40mg/4ml solution for infusion vials Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Opdivo 40mg/4ml concentrate for solution for infusion vials (Bristol-Myers Squibb Pharmaceuticals Ltd) Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Opdivo 100mg/10ml concentrate for solution for infusion vials (Bristol-Myers Squibb Pharmaceuticals Ltd) Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Nivolumab 40mg/4ml solution for infusion vials 1 vial Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Nivolumab 100mg/10ml solution for infusion vials 1 vial Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Opdivo 100mg/10ml concentrate for solution for infusion vials (Bristol-Myers Squibb Pharmaceuticals Ltd) 1 vial Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Opdivo 40mg/4ml concentrate for solution for infusion vials (Bristol-Myers Squibb Pharmaceuticals Ltd) 1 vial Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Potassium phosphate 17.42% (potassium 20mmol/10ml) solution for infusion 10ml ampoules (Special Order) Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Nivolumab BMS 40mg/4ml concentrate for solution for infusion vials (Bristol-Myers Squibb Pharmaceuticals Ltd) Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Nivolumab BMS 100mg/10ml concentrate for solution for infusion vials (Bristol-Myers Squibb Pharmaceuticals Ltd) Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Etoposide 100mg/5ml concentrate for solution for infusion vials (Actavis UK Ltd) Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Potassium phosphate 17.42% (potassium 20mmol/10ml) solution for infusion 10ml ampoules 1 ampoule Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Potassium phosphate 17.42% (potassium 20mmol/10ml) solution for infusion 10ml ampoules (Special Order) 10 ampoule Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Potassium phosphate 17.42% (potassium 20mmol/10ml) solution for infusion 10ml ampoules (Special Order) 1 ampoule Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Nivolumab BMS 40mg/4ml concentrate for solution for infusion vials (Bristol-Myers Squibb Pharmaceuticals Ltd) 1 vial Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Nivolumab BMS 100mg/10ml concentrate for solution for infusion vials (Bristol-Myers Squibb Pharmaceuticals Ltd) 1 vial Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Etoposide 100mg/5ml concentrate for solution for infusion vials (Actavis UK Ltd) 1 vial Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Etoposide 100mg/5ml concentrate for solution for infusion vials (Actavis UK Ltd) 10 vial Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Levosimendan 12.5mg/5ml solution for infusion vials Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Simdax 12.5mg/5ml concentrate for solution for infusion vials (Imported (Finland)) Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Levosimendan 12.5mg/5ml solution for infusion vials 1 vial Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Etoposide 100mg/5ml concentrate for solution for infusion vials (A A H Pharmaceuticals Ltd) 10 vial Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Simdax 12.5mg/5ml concentrate for solution for infusion vials (Imported (Finland)) 1 vial Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Morphine sulfate 100mg/50ml solution for infusion vials (Torbay Pharmaceuticals) Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
L-alanyl-l-glutamine 20g/100ml solution for infusion bottles 10 bottle Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
L-alanyl-l-glutamine 10g/50ml solution for infusion bottles 10 bottle Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Generic Aminoven 25 solution for infusion 500ml bottles 10 bottle Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Morphine sulfate 100mg/50ml solution for infusion vials 10 vial Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Morphine sulfate 100mg/50ml solution for infusion vials (Torbay Pharmaceuticals) 10 vial Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Aminoven 25 solution for infusion 500ml bottles (Fresenius Kabi Ltd) 10 bottle Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Dipeptiven 10g/50ml concentrate for solution for infusion bottles (Fresenius Kabi Ltd) 10 bottle Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Dipeptiven 20g/100ml concentrate for solution for infusion bottles (Fresenius Kabi Ltd) 10 bottle Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Sebelipase alfa 20mg/10ml solution for infusion vials Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Kanuma 20mg/10ml concentrate for solution for infusion vials (Alexion Pharma UK Ltd) Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Sebelipase alfa 20mg/10ml solution for infusion vials 1 vial Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Kanuma 20mg/10ml concentrate for solution for infusion vials (Alexion Pharma UK Ltd) 1 vial Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Sodium glycerophosphate 4.32g/20ml concentrate for solution for infusion vials (Fresenius Kabi Ltd) Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Sodium glycerophosphate 4.32g/20ml solution for infusion vials 10 vial Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Sodium glycerophosphate 4.32g/20ml concentrate for solution for infusion vials (Fresenius Kabi Ltd) 1 vial Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier
Sodium glycerophosphate 4.32g/20ml concentrate for solution for infusion vials (Fresenius Kabi Ltd) 10 vial Has dispensed dose form True Conventional release solution for infusion Inferred relationship Existential restriction modifier

Start Previous Page 48 of 71 Next End


This concept is not in any reference sets

Back to Start